Pfizer's oral Unasyn
Executive Summary
A 1987 NDA filing is targeted for an oral version of the ampicillin/sulbactam combo for treatment of ampicillin-resistant infections. A mid-year launch in Japan is planned. The injectable version was approved late in 1986. By year end, Pfizer will have filed six NDAs: Procardia GITS, Cardura, amlodipine, sertraline, certriline and oral Unasyn.